SNTI
Price:
$2.87
Market Cap:
$13.14M
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a mult...[Read more]
Industry
Biotechnology
IPO Date
2021-05-26
Stock Exchange
NASDAQ
Ticker
SNTI
According to Senti Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.15. This represents a change of -44.76% compared to the average of -0.27 of the last 4 quarters.
The mean historical PE Ratio of Senti Biosciences, Inc. over the last ten years is -18.97. The current -0.15 PE Ratio has changed -20.93% with respect to the historical average. Over the past ten years (40 quarters), SNTI's PE Ratio was at its highest in in the December 2023 quarter at 0. The PE Ratio was at its lowest in in the March 2021 quarter at -624078.29.
Average
-18.97
Median
-7.78
Minimum
-64.09
Maximum
-0.41
Discovering the peaks and valleys of Senti Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.41
Minimum Annual Increase = -91.87%
Minimum Annual PE Ratio = -64.09
Year | PE Ratio | Change |
---|---|---|
2023 | -0.41 | -34.84% |
2022 | -0.63 | -91.87% |
2021 | -7.78 | -64.53% |
2020 | -21.94 | -65.77% |
The current PE Ratio of Senti Biosciences, Inc. (SNTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.94
5-year avg
-18.97
10-year avg
-18.97
Senti Biosciences, Inc.’s PE Ratio is greater than ZIVO Bioscience, Inc. (-2.46), greater than Cadrenal Therapeutics, Inc. Common Stock (-1.34), greater than Foghorn Therapeutics Inc. (-4.49), greater than Quoin Pharmaceuticals, Ltd. (-0.47), greater than SAB Biotherapeutics, Inc. (-0.65), greater than Cingulate Inc. (-1.82), less than Bellicum Pharmaceuticals, Inc. (-0.11), less than Hillstream BioPharma, Inc. (-0.00), less than Lipella Pharmaceuticals Inc. (-0.00), less than Fennec Pharmaceuticals Inc. (54.24), greater than Monopar Therapeutics Inc. (-1.18), less than Applied Molecular Transport Inc. (-0.14), greater than Neoleukin Therapeutics, Inc. (-0.98), greater than SAB Biotherapeutics, Inc. (-0.65), greater than Connect Biopharma Holdings Limited (-3.00), greater than Tyra Biosciences, Inc. (-14.94), greater than RAPT Therapeutics, Inc. (-0.59), greater than Xilio Therapeutics, Inc. (-0.72), greater than Mineralys Therapeutics, Inc. (-4.63),
Company | PE Ratio | Market cap |
---|---|---|
-2.46 | $37.03M | |
-1.34 | $8.36M | |
-4.49 | $416.63M | |
-0.47 | $3.06M | |
-0.65 | $26.03M | |
-1.82 | $12.90M | |
-0.11 | $778.33K | |
-0.00 | $4.17M | |
-0.00 | $4.10M | |
54.24 | $144.76M | |
-1.18 | $8.41M | |
-0.14 | $11.01M | |
-0.98 | $8.20M | |
-0.65 | $26.21M | |
-3.00 | $68.88M | |
-14.94 | $1.09B | |
-0.59 | $63.87M | |
-0.72 | $35.74M | |
-4.63 | $558.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senti Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Senti Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Senti Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Senti Biosciences, Inc. (SNTI)?
What is the highest PE Ratio for Senti Biosciences, Inc. (SNTI)?
What is the 3-year average PE Ratio for Senti Biosciences, Inc. (SNTI)?
What is the 5-year average PE Ratio for Senti Biosciences, Inc. (SNTI)?
How does the current PE Ratio for Senti Biosciences, Inc. (SNTI) compare to its historical average?